Bulldog Investors’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Bulldog Investors’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-55,685	Closed	-$562K	–	322
2022 Q4	$562K	Buy	+55,685	New	+$557K	0.17%	133

Bulldog Investors's BIOT Position: Q1 2023 in Review

Bulldog Investors sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 55,685 shares — an estimated $562K sold.

Bulldog Investors first reported a position in BIOT in Q4 2022 and held it in 1 quarter. The position peaked at $562K in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

Bulldog Investors reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Bulldog Investors sold 55,685 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $562K.
Bulldog Investors first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q4 2022 and held it in 1 quarter.
Bulldog Investors's Biotech Acquisition Company Class A Ordinary Shares position peaked at $562K in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on Bulldog Investors's 13F filing for Q1 2023, filed 15 May 2023.